MX2007009368A - Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos. - Google Patents

Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos.

Info

Publication number
MX2007009368A
MX2007009368A MX2007009368A MX2007009368A MX2007009368A MX 2007009368 A MX2007009368 A MX 2007009368A MX 2007009368 A MX2007009368 A MX 2007009368A MX 2007009368 A MX2007009368 A MX 2007009368A MX 2007009368 A MX2007009368 A MX 2007009368A
Authority
MX
Mexico
Prior art keywords
collagen synthesis
subject
treatment
kgf expression
kgf
Prior art date
Application number
MX2007009368A
Other languages
English (en)
Inventor
Sung-Hoon Kim
Original Assignee
Imagene Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imagene Co Ltd filed Critical Imagene Co Ltd
Publication of MX2007009368A publication Critical patent/MX2007009368A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se relaciona con un metodo para estimular la sintesis de colageno y/o expresion de KGF, y mas en particular un metodo para estimular la sintesis de colageno y/o expresion de KGF utilizando AIPM1 o su fragmento; AIMP1 o su fragmento puede utilizarse efectivamente para la estimulacion de sintesis de colageno y/o expresion de KGF en un sujeto que lo necesite, el tratamiento de envejecimiento de la piel en el sujeto, el tratamiento de piel flacida y/o arrugada en el sujeto, promocion del alisado y/o firmeza de la piel en el sujeto, el tratamiento de efectos cutaneos adversos de menopausia en el sujeto, y el tratamiento de efectos adversos de menopausia en el colageno.
MX2007009368A 2005-02-01 2006-01-24 Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos. MX2007009368A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2005000300 2005-02-01
PCT/KR2006/000275 WO2006083087A1 (en) 2005-02-01 2006-01-24 Method for stimulation collagen synthesis and/or kgf expression

Publications (1)

Publication Number Publication Date
MX2007009368A true MX2007009368A (es) 2008-01-14

Family

ID=36777436

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007009368A MX2007009368A (es) 2005-02-01 2006-01-24 Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos.

Country Status (9)

Country Link
US (1) US20100167997A1 (es)
EP (1) EP1848395A4 (es)
JP (1) JP2008528577A (es)
KR (1) KR100903984B1 (es)
CN (1) CN101111222A (es)
AU (1) AU2006211730A1 (es)
CA (1) CA2596597C (es)
MX (1) MX2007009368A (es)
WO (1) WO2006083087A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007083853A1 (en) 2006-01-23 2007-07-26 Imagene Co., Ltd. Novel peptide and use thereof
WO2008031196A1 (en) * 2006-09-13 2008-03-20 Enhance Skin Products, Inc. Treatment of aged skin with autologous growth factors in a hyaluronic acid delivery system
CA2676640A1 (en) * 2007-02-01 2008-08-07 Imagene Co., Ltd. Novel polypeptide having anti-tumor activity
EP2153814A1 (en) 2008-08-05 2010-02-17 Isdin S.A. Use of compositions comprising urea
EP2153815A1 (en) 2008-08-05 2010-02-17 Isdin S.A. Use of urea containing compositions
WO2010099477A2 (en) 2009-02-27 2010-09-02 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
EP3255146B1 (en) 2009-03-16 2019-05-15 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
CA2783731C (en) 2009-12-11 2018-03-27 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating inflammation
US20110245182A1 (en) * 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20110245183A1 (en) * 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
AU2011289833C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
WO2013115926A2 (en) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Aspartyl-trna synthetase-fc conjugates
NZ628126A (en) 2012-02-16 2016-10-28 Atyr Pharma Inc Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
ITRM20120404A1 (it) 2012-08-09 2014-02-10 Univ Roma Uso del kgf nel trattamento di disturbi della menopausa
DK3460054T3 (da) 2013-03-15 2021-01-18 Atyr Pharma Inc Histidyl-tRNA-syntetase-Fc-konjugater
WO2017082692A1 (ko) * 2015-11-12 2017-05-18 주식회사 펩트론 미백, 피부 탄력 및 주름 개선 활성을 갖는 다기능성 피부투과 펩타이드
KR101996490B1 (ko) * 2016-05-31 2019-07-03 인하대학교 산학협력단 간질환 예방 또는 치료용 펩타이드 및 이를 유효성분으로 포함하는 조성물
KR102017796B1 (ko) 2016-07-28 2019-09-03 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
KR102336341B1 (ko) * 2016-07-28 2021-12-08 주식회사 네오믹스 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 피부 보호용 조성물
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
WO2018199633A1 (ko) * 2017-04-25 2018-11-01 (주)피알지에스앤텍 데커신 유도체를 유효성분으로 함유하는 노화 관련 질환 예방 또는 치료용 약학조성물
KR102070328B1 (ko) 2017-04-25 2020-01-28 (주)피알지에스앤텍 데커신 유도체를 유효성분으로 함유하는 노화 관련 질환 예방 또는 치료용 약학조성물
CN107383163B (zh) * 2017-07-03 2019-10-11 择天生物科技（大连）有限公司 一类促胶原分泌超短肽及其应用
KR102230488B1 (ko) * 2018-10-05 2021-03-23 (주)피알지에스앤텍 데커신 유도체를 유효성분으로 함유하는 노화 관련 질환 예방 또는 치료용 약학조성물
KR102346050B1 (ko) * 2019-01-25 2022-01-03 주식회사 네오믹스 미백 활성을 갖는 신규 폴리펩타이드 및 이의 용도
KR102024055B1 (ko) * 2019-08-14 2019-09-24 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
CN111961119B (zh) * 2020-09-02 2021-03-12 方晓东 多肽在制备促进胶原蛋白分泌的药物或化妆品中的用途
WO2022128048A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for preventing or treating pathologic conditions of human skin

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) * 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP3159419B2 (ja) * 1993-12-28 2001-04-23 カネボウ株式会社 化粧料
JP3591950B2 (ja) * 1995-12-19 2004-11-24 株式会社テクノーブル 老化防止化粧料およびそれに用いるｓｏｄ様活性作用剤
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
US6800286B1 (en) * 1998-08-19 2004-10-05 The Regents Of The University Of Colorado Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
AU776679B2 (en) * 1998-11-13 2004-09-16 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
WO2000051561A1 (fr) * 1999-03-02 2000-09-08 Kyowa Hakko Kogyo Co., Ltd. Produits cosmetiques
WO2000054750A1 (fr) * 1999-03-15 2000-09-21 Dmitry Anatolievich Starchenko Procede de correction des perturbations dans la synthese du collagene et substance bioactive de mise en oeuvre de ce procede
US6245812B1 (en) * 1999-07-15 2001-06-12 Charlotte Gollobin Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids
WO2001095927A1 (en) * 2000-06-14 2001-12-20 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokine domain
KR100405919B1 (ko) * 2001-06-05 2003-11-14 주식회사 이매진 ｐ43의 Ｎ-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물
US7094754B2 (en) * 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
ES2272555T3 (es) * 2001-12-14 2007-05-01 Matthias Rath Composicion de estrogeno y otras hormonas con ascorbato, lisina, prol ina y otras sustancias.
JP2003335625A (ja) * 2002-05-14 2003-11-25 E-S International:Kk 皮膚外用剤
US20040033246A1 (en) * 2002-06-25 2004-02-19 Kose Corporation Cosmetic for prevention of skin aging and agent for prevention of skin aging
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 ｐ43을 유효성분으로 하는 창상 치료용 약학적 조성물
JP4286513B2 (ja) * 2002-09-26 2009-07-01 株式会社ファンケル 抗老化用組成物
WO2007083853A1 (en) * 2006-01-23 2007-07-26 Imagene Co., Ltd. Novel peptide and use thereof
CA2676640A1 (en) * 2007-02-01 2008-08-07 Imagene Co., Ltd. Novel polypeptide having anti-tumor activity

Also Published As

Publication number Publication date
KR20070100329A (ko) 2007-10-10
WO2006083087A1 (en) 2006-08-10
EP1848395A1 (en) 2007-10-31
KR100903984B1 (ko) 2009-06-25
CA2596597A1 (en) 2006-08-10
US20100167997A1 (en) 2010-07-01
JP2008528577A (ja) 2008-07-31
EP1848395A4 (en) 2012-06-06
CN101111222A (zh) 2008-01-23
CA2596597C (en) 2011-05-17
AU2006211730A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
MX2007009368A (es) Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos.
SG149027A1 (en) Substituted urea derivatives for treating cardiac diseases
TW200637522A (en) Skin treatment articles and methods
WO2006040688A3 (en) Inhibitors of acetylcholinesterase for treating skin diseases
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
ATE356607T1 (de) Verwendung von nativem zein zur verbesserung des haarzustandes und mittel
CR11486A (es) Tratamiento de cancer uterino y cancer de ovario con un inhibidor de parp solo o en combinacion con agentes anti-tumorales
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
UA94922C2 (ru) Способ регулирования специфичности сигнализации тканевого фактора у млекопитающего, которое нуждается в этом, способ идентификации агента, который специфически ингибирует сигнализацию тканевого фактора
NZ571858A (en) Methods of treating, reducing and inhibiting the appearance of ageing in the skin
HK1124918A1 (zh) +- 宫頸非典型增生和宫頸癌中的 +、 +腺苷三磷酸酶表達
GB2419186C (en) Method to measure the effect of topically applied agents using skin maintained in organ culture.
ZA200703441B (en) Coadministration of tigecycline and digoxin
EP1648399A4 (en) METHOD AND TOPIC COMPOSITION FOR TREATING SKIN HYPERPIGMENTATION
ZA200703531B (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
IL190850A0 (en) Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
WO2011009757A3 (de) Verwendung von humanem beta-defensin zur beeinflussung des natürlichen pigmentierungsprozesses
GB0304367D0 (en) Methods for treating psoriasis
TW200603792A (en) Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
MX2009010757A (es) Metodos de uso de compuestos de inhibidor gamma para atenuacion del dolor.
ECSP055715A (es) Utilizacion de pirimetanilo en patogenos resistentes
TW200642688A (en) New use of PDE7 inhibitors